ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 933

Tumor Necrosis Factor Inhibitors Slow Radiologic Progression in Patients with Ankylosing Spondylitis: 18-year Longitudinal Cohort Study

Bon San Koo1, Ji Seon Oh 2, Seo Young Park 3, Ga Young Ahn 4, Seunghun Lee 5, Kyung Bin Joo 6 and Tae-Hwan Kim 7, 1Department of Internal Medicine, Inje University Seoul Paik Hospital, Inje University College of Medicine, Seoul, Republic of Korea, 2Department of Biomedical Informatics, Asan Medical Center, Seoul, Korea, Seoul, Republic of Korea, 3Department of Clinical Epidemiology and Biostatistics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Seoul-t'ukpyolsi, Republic of Korea, 4Korea University Guro Hospital, Seoul, Republic of Korea, 5Dertment of Radiology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea, 6Department of Radiology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Seoul-t'ukpyolsi, Republic of Korea, 7Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Ankylosing spondylitis (AS), anti-TNF therapy, Disease Activity and radiography, modified stoke ankylosing spondylitis spinal score (MSASSS)

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 10, 2019

Session Title: 3S111: Spondyloarthritis Including Psoriatic Arthritis – Clinical II: Axial Spondyloarthritis Treatment (933–938)

Session Type: ACR Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: It is difficult to evaluate the role of TNF inhibitor therapy in slowing the radiologic progression in patients with ankylosing spondylitis (AS) because of frequent changes in disease activity and medication. In addition, the role of TNF inhibitors in slowing the radiologic progression was underestimated because most patients starting TNF inhibitors were in a high inflammatory state. Therefore, an analysis of time varying compounders such as disease activity is essential. The aim of this study was to investigate whether long-term treatment with TNF inhibitors can reduce radiographic progression in patients with AS using an 18-year longitudinal cohort data.

Methods: Of the 1,280 patients who followed for 18 years in single center cohort, data of 328 patients treated with TNF inhibitors were included. For each patient who received TNF inhibitors, the time interval was categorized based on the patient’s TNF inhibitor status (‘on the TNF inhibitors’ and ‘off the TNF inhibitors’ intervals). The data were analyzed using the Modified Stoke Ankylosing Spondylitis Spinal Score (mSASSS), erythrocyte sedimentation rate (ESR), c-reactive protein (CRP), and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and imputed at each time point by linear interpolation. We obtained 2315 intervals (1,063 intervals ‘on the TNF inhibitors’ and 1,252 intervals ‘off the TNF inhibitors’) from 328 patients with computable intervals. A multivariable linear regression with compound symmetry correlation structure within each patient was performed using a generalized estimating equation for rate of change in mSASSS (per year) as the outcome, and with ESR, CRP, and BASDAI as the time-varying covariate. A marginal structural model for inverse probability of treatment weighting (MSM with IPTW) was constructed to evaluate the underestimated effect of TNF inhibitors.

Results: The rate of mSASSS significantly decreased with the use of TNF inhibitors (b=-0.054, p=0.023 in the multivariable model) (Table 1). The adjusted rate of mSASSS with multivariable analysis was 0.916 per year during ‘on the TNF inhibitors’ and 0.970 per year during ‘off the TNF inhibitors’ period when the other covariates were fixed at their mean values. However, the role of TNF inhibitors was underestimated on the rate of mSASSS because ESR and CRP at the start of interval were significantly higher in ‘on the TNF inhibitors intervals (b=-5.946, p< 0.001 and b=0.412, p< 0.001, respectively). To eliminate the effects of confounding variables such as ESR and CRP on the mSASSS, we created a pseudo-population using an IPTW. (Table 2) The rate of mSASSS showed a greater decrease with the use of TNF inhibitors (b=-0.111, p< 0.001) than in the multivariable regression model. The adjusted rate of mSASSS was 0.848 per year during ‘on the TNF inhibitors’ and 0.959 per year during ‘off the TNF inhibitors’ intervals.

Conclusion: TNF inhibitor treatment significantly slowed radiologic progression when compared to other therapies. In addition, the effect of TNF inhibitors on radiological progress has been previously underestimated.


20190601 mSASSS_table1


20190601 mSASSS_table2


Disclosure: B. Koo, None; J. Oh, None; S. Park, None; G. Ahn, None; S. Lee, None; K. Joo, None; T. Kim, None.

To cite this abstract in AMA style:

Koo B, Oh J, Park S, Ahn G, Lee S, Joo K, Kim T. Tumor Necrosis Factor Inhibitors Slow Radiologic Progression in Patients with Ankylosing Spondylitis: 18-year Longitudinal Cohort Study [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/tumor-necrosis-factor-inhibitors-slow-radiologic-progression-in-patients-with-ankylosing-spondylitis-18-year-longitudinal-cohort-study/. Accessed July 1, 2022.
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/tumor-necrosis-factor-inhibitors-slow-radiologic-progression-in-patients-with-ankylosing-spondylitis-18-year-longitudinal-cohort-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2022 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies